Jaroslav Benedík
Masaryk University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jaroslav Benedík.
Journal of Clinical Virology | 2000
Radek Horváth; Jan Černý; Jaroslav Benedík; Jan Hokl; Ivana Jelı́nková
BACKGROUND The biological properties of some herpesviruses such as the ability of latent persistency in the host cells and the presence of viral DNA in atherosclerotic lesions, suggest the possible role of herpesviruses in the development of atherosclerosis. Although many authors proved the presence of viral DNA in arterial wall tissue, the role of herpesviruses in the origin and progress of atherogenesis still remains unclear. OBJECTIVES The aim of this study was to confirm the presence of viral DNA in arterial wall and to associate the presence of these viruses with the development of atherosclerosis in patients with ischemic heart disease (IHD). STUDY DESIGN A possible role of HCMV, EBV and HHV6 in the development of atherosclerosis was tested in 244 IHD patients and 87 coronarographically negative controls. The presence of viral DNA in aortic and venous walls, as well as in a peripheral blood samples was tested by the use of polymerase chain reaction (PCR) accompanied by, immunological tests for anti-virus antibodies IgM and IgG types for all experimental groups. RESULTS The genomic DNA of HCMV was found in 76 and 59%, DNA of EBV in 59 and 50%, and DNA of HHV6 in 0.08 and 0.0%, of arterial walls of IHD patients and non-ischemic control group, respectively. No viral DNA was found in venous samples. Significant association (P < 0.01) has been proved between CMV infection and IHD. CONCLUSIONS Our results suggest that HCMV and EBV can be found in the arterial wall, so that the arterial wall could be a potential site of persistency of those viruses. We also proved a significant association between the presence of HCMV DNA in aortic walls and atherosclerosis. Despite of the high genetic and biological similarity between CMV and HHV6 no substantial role of HHV6 in atherosclerosis has been proved.
Pediatric Hematology and Oncology | 1999
Jaroslav Michálek; Radek Horváth; Jaroslav Benedík; Hana Hrstková
Pediatric cancer patients treated with multimodal therapy are at a great risk of opportunistic infections or reactivation of latent infections. Human herpesvirus-6 (HHV-6) can serve as an example of such infection, with high seroprevalence in population. In 66 children with cancer and in 45 healthy controls, age matched, the presence of DNA HHV-6 was examined in peripheral blood by the polymerase chain reaction method. HHV-6 serology was also performed. No difference has been found between patients at the time of cancer diagnosis and the group of healthy children in the presence of DNA HHV-6 in blood, 17.4 and 15.6%, respectively. During cytotoxic chemotherapy the presence of HHV-6 in peripheral blood raised to 37.1% in patients with fever. Other parameters and symptoms such as febrile neutropenia, lymphopenia, exanthem, hepatopathy, lymphadenopathy, enteritis, bone marrow aplasia, pneumonitis, and encephalitis were examined in both the HHV-6 positive and HHV-6 negative groups of pediatric cancer patients. Statistically significant differences (p < .05) were found in case of lymphopenia, exanthem, and hepatopathy. In 4 out of 66 patients (6.1%) severe HHV-6 infection has been found: in 3 patients during cytotoxic chemotherapy and in 1 at the time of cancer diagnosis. Reactivation of HHV-6 infection in pediatric cancer patients under treatment with cytotoxic chemotherapy is frequent and can lead to severe complications as described in patients after bone marrow or organ transplantation.
Clinical Genetics | 2001
Petr Beneš; Jan Mužík; Jaroslav Benedík; Lubomír Elbl; Vladimír Znojil; Jiří Vácha
In summary, the presented data indicate that a common polymorphism in the LRPAP1 gene coding for RAP is associated with variations in the plasma concentration of apoAI and HDL in Czech CAD patients.
Atherosclerosis | 2000
Petr Beneš; Jan Mužík; Jaroslav Benedík; Lubomír Elbl; Vladimı́ra Znojil; Jiří Vácha
Our findings show that the apo B Ins/Del polymorphism affects plasma lipoprotein and apolipoprotein levels in male CAD patients and that the Ins allele is associated with the type II diabetes mellitus in these patients with a marginal significance.
Epidemiology and Infection | 2004
Radek Horváth; Miloš Dendis; Jarmila Schlegelová; Filip Růžička; Jaroslav Benedík
The original method for molecular typing of E. coli strains was developed using the polymorphism in chromosomal sequences of bacterial interspersed mosaic elements (BIMEs) detected by multiplex PCR and analysed by AFLP assay. The applicability of the method in the epidemiology of E. coli was tested on a group of 524 strains of human and veterinary origin. In the studied group 18 different genotypes were detected. Significant differences were found in the frequencies of the genotypes among various groups of strains, suggesting the method could be a promising tool in the epidemiology of E. coli.
Molecular Genetics and Metabolism | 2001
Petr Beneš; Kateřina Kaňková; Jan Mužík; Ladislav Groch; Jaroslav Benedík; Lubomír Elbl; Lydie IzakovičováHollá; Anna Vašků; Vladimír Znojil; Jiří Vácha
Clinical Microbiology and Infection | 2003
Miloš Dendis; Radek Horváth; Jaroslav Michálek; Filip Růžička; M. Grijalva; M. Bartoš; Jaroslav Benedík
Journal of Molecular Medicine | 2001
Petr Beneš; Jan Mužík; Jaroslav Benedík; Lubomír Elbl; Anna Vašků; Lenka Šišková; Vladimír Znojil; Jiří Vácha
Molecular Genetics and Metabolism | 2000
Petr Beneš; Jan Mužík; Jaroslav Benedík; Milan Frélich; Lubomír Elbl; Anna Vašků; Vladimír Znojil; Jiří Vácha
Human Biology | 2002
Jan Muzík; Jaroslav Benedík; Vladimír Znojil; Jirí Vácha